Zobrazeno 1 - 10
of 706
pro vyhledávání: '"Interferon type II"'
Autor:
Alvaro Santibañez, Diego Paine, Mick Parra, Carlos Muñoz, Natalia Valdes, Claudia Zapata, Rodrigo Vargas, Alex Gonzalez, Mario Tello
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Lactic acid bacteria are a powerful vehicle for releasing of cytokines and immunostimulant peptides at the gastrointestinal level after oral administration. However, its therapeutic application against pathogens that affect rainbow trout and Atlantic
Externí odkaz:
https://doaj.org/article/d6aac0cfdbe44bb28e6c4175b3252215
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 14, Iss 10, Pp 867-872 (2014)
Objective Multiple sclerosis (MS) is a mainly cell-mediated autoimmune demyelinating disease in central nervous system (CNS), characterized by inflammatory demyelinating and infiltration of mononuclear cells around microvessels in CNS. It has been sh
Externí odkaz:
https://doaj.org/article/588e90b4b27f4d2a9d0d10b7da29e48d
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 14, Iss 8, Pp 680-686 (2014)
Background Cryptococcal meningitis (CM) is the most common fungal infection of central nervous system, caused by Cryptococcus neoformans infection of the meninges. The development and prognosis of CM depend on the patient's own immune function to som
Externí odkaz:
https://doaj.org/article/881d9406a3df4b0dbb90b2b634b5ed33
Publikováno v:
British Journal of Surgery. 108
Introduction The polymeric immunoglobulin receptor (PIGR) is a transmembrane protein, which transports polymeric immunoglobulin (pIg) across the epithelial cells. High expression of PIGR in breast cancer has been reported to associate with increased
Publikováno v:
Vojnosanitetski Pregled, Vol 61, Iss 2, Pp 137-143 (2004)
Severe sepsis and trauma complicated with multiple organ dysfunction syndrome (MODS) are among the leading causes of death in intensive therapy units with mortality rate exceeding 50%. The outcome is not determined only by infection or trauma, but al
Externí odkaz:
https://doaj.org/article/26c6b25e6046485197f60ea14767eedb
Publikováno v:
Clinical and Experimental Immunology. 200:299-301
Autor:
Jeffrey L. Harrison, Gregory P. Takacs, Maryam Rahman, Christian Kreiger, Defang Luo, Duane Mitchell, Loic P. Deleyrolle, Joseph Flores-Toro
Publikováno v:
Neuro-Oncology. 23:vi92-vi93
INTRODUCTION Mounting evidence suggests infiltrating immune-suppressive cells contribute to immune checkpoint inhibitor resistance and poor survival in Glioblastoma (GBM) patients. We have previously shown glioma-associated monocytic-myeloid derived
Autor:
Duane Mitchell, David Shin, Connor Francis, Brandon Wummer, Ginger Moore, Bayli DiVita Dean, Catherine Flores
Publikováno v:
Neurosurgery. 67
Autor:
Konrad Thorner, Sebastian Snedal, Jongmyung Kim, Daniel Abate-Daga, Marine Potez, María Cecilia Ramello, James K. Liu
Publikováno v:
Neuro Oncol
Glioblastoma (GBM) is the most aggressive primary brain tumor with high mortality rates and resistance to conventional therapy. Their resistance to conventional therapy has been attributed to the presence of cancer stem cells (CSCs), a sub-population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7f4553da8467f091b7bbee3f0dbc0d2
https://europepmc.org/articles/PMC7651385/
https://europepmc.org/articles/PMC7651385/
Autor:
Craig Horbinski, Aurora Lopez-Rosas, Jason Miska, Víctor A. Arrieta, Aida Rashidi, Yu Han, Rachel A. Burga, Roger Stupp, Adam M. Sonabend, Ting Xiao, Daniel Zhang, Peng Zhang, Ignacio Jusue Torres, Maciej S. Lesniak, Irina V. Balyasnikova, David Hou, Catalina Lee Chang
Publikováno v:
Neuro Oncol
Immunotherapy has revolutionized the treatment of many tumors. However, most glioblastoma (GBM) patients have not, so far, benefited from such successes. With the goal of exploring ways to boost anti-GBM immunity, we developed a B-cell-based vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::119ec00ba968b16435bfc50ca21a3f20
https://europepmc.org/articles/PMC7651425/
https://europepmc.org/articles/PMC7651425/